Smith, Erin
Ali, Diab
Wilkerson, Bill
Dawson, Walter D. http://orcid.org/0000-0002-1172-0471
Sobowale, Kunmi
Reynolds, Charles III
Berk, Michael
Lavretsky, Helen
Jeste, Dilip
Ng, Chee H.
Soares, Jair C.
Aragam, Gowri
Wainer, Zoe
Manji, Husseini K.
Licinio, Julio http://orcid.org/0000-0001-6905-5884
Lo, Andrew W.
Storch, Eric
Fu, Ernestine
Leboyer, Marion
Tarnanas, Ioannis http://orcid.org/0000-0003-4069-6551
Ibanez, Agustin http://orcid.org/0000-0001-6758-5101
Manes, Facundo
Caddick, Sarah
Fillit, Howard
Abbott, Ryan
Robertson, Ian H.
Chapman, Sandra B.
Au, Rhoda
Altimus, Cara M.
Hynes, William
Brannelly, Patrick
Cummings, Jeffrey
Eyre, Harris A. http://orcid.org/0000-0003-4827-8258
Article History
Received: 16 July 2020
Revised: 16 September 2020
Accepted: 5 October 2020
First Online: 26 October 2020
Compliance with ethical standards
:
: JC has provided consultation to Acadia, Actinogen, Alkahest, Alzheon, AnnovisBio, Avanir, Axsome, BiOasis, Biogen, Cassava, Cerecin, Cortexyme, Cytox, Diadem, EIP Pharma, Eisai, Foresight, GemVax, Genentech, Green Valley, Grifols, Maplight, Merck, Otsuka, Resverlogix, Roche, Samumed, Samus, Signant, Third Rock, and United Neuroscience pharmaceutical and assessment companies. JC has stock options in ADAMAS, MedAvante, QR pharma/AnnovisBio, BiOasis. Ryan Abbott works as an attorney and consult to a variety of commercial enterprises in the life science and information technology fields. AWL reports personal investments in public and private biotech companies, biotech venture capital funds, and biotech mutual funds. He is a director of BridgeBio Pharma and Roivant Sciences, and a member of the Board of Overseers at Beth Israel Deaconess Medical Center and the NIH’s National Center for Advancing Translational Sciences Advisory Council and Cures Acceleration Network Review Board. He is a co-founder and partner of QLS Advisors, a health care analytics company; an advisor to BrightEdge Ventures, the impact fund of the American Cancer Society; and chairman emeritus and senior advisor to AlphaSimplex Group, an asset management company he founded in 1999. CR receives a stipend from the American Association for Geriatric Psychiatry for editing the <i>American Journal of Geriatric Psychiatry</i>; royalty income from the University of Pittsburgh as co-inventor of the Pittsburgh Sleep Quality Inventory. IT reports income and stock in ALTOIDA LLC and has a patent “Apparatus, method and program for determining a cognitive state of a user of a mobile device” pending. HAE receives fees from PRODEO LLC, PreActive Technologies INC and ALTOIDA LLC. CHN had served as a consultant for Lundbeck, Grunbiotics, Servier, Janssen-Cilag, and Eli Lilly, received research grant support from Lundbeck, and speaker honoraria from Servier, Lundbeck, Bristol-Myers Squibb, Organon, Eli Lilly, GlaxoSmithKline, Janssen-Cilag, Astra-Zenaca, Wyeth, and Pfizer. WDD reports personal fees from Commonwealth Fund, personal fees from AARP, personal fees from Insights to Illuminate, LLC, personal fees from Cognitive Solutions, LLC, personal fees from Oregon Health Care Association, personal fees from Mather LifeWays, personal fees from Splaine Consulting, outside the submitted work. E. Storch reports consulting fees from Levo Therapeutics; Honoraria from International OCD Foundation; and book royalties from Wiley, Elsevier, Springer, American Psychological Association, Oxford, Jessica Kingsley, Lawrence Erlbaum. The contents of this publication are solely the responsibility of the authors and do not represent the official views of these Institutions. No other co-authors have disclosures.
Free to read: This content has been made available to all.